Vetrepharm ApS: Financial statements 2016
CVR: 15206802
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 49,915 and a net result of DKK -25,566 compared with DKK 199,999 the year before. That is a decrease of 92.6% compared with the year before. Equity in the 2016 report amounted to DKK 1,077,753. The solvency ratio was 92.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 49,915
- Profit/Loss
- DKK -25,566
- Equity
- DKK 1,077,753
- Total Assets
- DKK 1,160,584
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 50 t. | -26 t. | 1.1 mio. | 1 |
| 2015 | - | 678 t. | 200 t. | 1.6 mio. | - |
| 2014 | - | 1.1 mio. | 510 t. | 1.4 mio. | - |
| 2013 | - | 1.1 mio. | 466 t. | 1.4 mio. | - |
| 2012 | - | 1 mio. | 289 t. | 1.4 mio. | - |
Official annual report
Find more companies like Vetrepharm ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
Vetrepharm ApS has published its annual report for 2015. Gross profit came to DKK 677,574, and the net result was DKK 199,999.
About Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.